| References: |
PF-429242 is a potent inhibitor of S1P (cellular proprotein convertase sterol regulatory element-binding protein (SREBP) site 1 protease) that reduces expression levels of hepatic SREBP target genes and lower rates of cholesterol and fatty acid synthesis in mice. PF-429242 is a potent antiviral agent against prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) and LASV in cultured cells. PF-429242 efficiently prevented the processing of GPC from the LCMV and LASV. PF-429242 is expected to be active against CCHFV. For the detailed information of PF 429242, the solubility of PF 429242 in water, the solubility of PF 429242 in DMSO, the solubility of PF 429242 in PBS buffer, the animal experiment (test) of PF 429242, the cell expriment (test) of PF 429242, the in vivo, in vitro and clinical trial test of PF 429242, the EC50, IC50,and affinity,of PF 429242, For the detailed information of PF 429242, the solubility of PF 429242 in water, the solubility of PF 429242 in DMSO, the solubility of PF 429242 in PBS buffer, the animal experiment (test) of PF 429242, the cell expriment (test) of PF 429242, the in vivo, in vitro and clinical trial test of PF 429242, the EC50, IC50,and affinity,of PF 429242, Please contact DC Chemicals. |
